Every Form 4 that CACI INTERNATIONAL CLA (CACI) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow CACI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CACI filings page.
Eric Blazer, CACI’s SVP, Corp. Controller & CAO, exercised or converted 590 performance restricted stock units and 99 restricted stock units into CACI common stock on October 16, 2026. The transactions also report 178 and 30 common shares delivered or withheld for payment of exercise price or tax liability, respectively, at $614.31 per share. The derivative holdings shown after each conversion were zero.
CACI International Inc director Philip O. Nolan received a direct award of 328 Restricted Stock Units on October 15, 2026, tied to CACI Common Stock. His reported direct position after the award was 328 units. The units vest in four installments of 82 shares each, scheduled for January 13, April 13, July 12, and October 10, 2027.
CACI International Inc. director Lisa S. Disbrow was granted 50 shares of common stock on October 15, 2026, in connection with her annual retainer as Chair of the Board. She was also granted 418 restricted stock units, which vest in installments from January 13, 2027, through October 10, 2027. Following the common-stock grant, her reported directly held position was 2,683 shares.
CACI International Inc. (CACI) director Scott C. Morrison received 328 Restricted Stock Units on October 15, 2026. The units vest in four installments of 82 shares each: January 13, April 13, July 12, and October 10, 2027. His reported direct position after the grant was 328 Restricted Stock Units.
CACI director Debora A. Plunkett was granted 328 Restricted Stock Units on October 15, 2026, representing 328 shares of CACI common stock. The units are reported as directly held and vest in four installments of 82 shares: January 13, April 13, July 12, and October 10, 2027.
CACI International Inc. director Charles L. Szews was granted 328 Restricted Stock Units on October 15, 2026. The award schedule provides for 82 shares to vest on January 13, 2027, 82 shares on April 13, 2027, 82 shares on July 12, 2027, and 82 shares on October 10, 2027.
CACI International Inc. director Susan M. Gordon received a direct grant of 328 Restricted Stock Units on October 15, 2026. The award represents 328 underlying CACI common shares, and her reported position after the grant was 328 Restricted Stock Units. The transaction is reported as a grant or award acquisition.
CACI director David F. Keffer received 328 restricted stock units on October 15, 2026. The units relate to CACI common stock and are scheduled to vest in four installments of 82 shares each, from January 13 through October 10, 2027. His reported position after the grant was 328 restricted stock units.
CACI director Michael M. Gilday was granted 328 Restricted Stock Units on October 15, 2026; his reported direct post-transaction position was 328 units. The units vest in four installments of 82 shares on January 13, 2027, April 13, 2027, July 12, 2027, and October 10, 2027.
CACI director Stanton D. Sloane was granted 328 Restricted Stock Units on October 15, 2026. The award is reported as directly owned and covers 328 shares of CACI common stock. The units are scheduled to vest in four installments of 82 shares: January 13, April 13, July 12, and October 10, 2027.
CACI International Inc. director Scott C. Morrison converted 85 Restricted Stock Units into 85 shares of CACI common stock on October 11, 2026. After the conversion, he directly held 669 common shares, while the reported Restricted Stock Unit position was 0.
The units came from a 338-unit grant made October 16, 2025. Its vesting schedule listed installments of 84, 84, 85 and 85 shares on January 14, April 14, July 13 and October 11, 2026, respectively.
CACI International Inc director Charles L. Szews reported the exercise of 85 restricted stock units on October 11, 2026, corresponding to the acquisition of 85 CACI common shares. The units were granted October 16, 2025 and vested in installments of 84 shares on January 15, 2026, 84 shares on April 15, 2026, 85 shares on July 15, 2026, and 85 shares on October 11, 2026. After the transaction, Szews directly held 669 common shares; the reported restricted-stock-unit position was zero.
CACI director Ryan D. McCarthy converted 85 restricted stock units into 85 shares of CACI common stock on October 11, 2026. His direct common-stock holdings were 2,407 shares after the transaction. The award footnote says the 338 restricted stock units were granted October 16, 2025, with scheduled vesting of 84 shares on January 15, 2026, 84 shares on April 15, 2026, 85 shares on July 15, 2026, and 85 shares on October 11, 2026.
CACI director Debora A. Plunkett converted 85 Restricted Stock Units into 85 shares of CACI common stock on October 11, 2026. Her reported direct common-stock holdings after the transaction were 2,682 shares, and the reported balance of the converted Restricted Stock Units was zero. The 85-unit installment was part of a grant of 338 Restricted Stock Units made October 16, 2025.
CACI International Inc. director Lisa S. Disbrow had 123 Restricted Stock Units vest on October 11, 2026, acquiring 123 shares of CACI common stock. Her direct common-stock holdings after the transaction were 2,633 shares, and her reported RSU position was zero. The units were part of a 492-RSU award granted October 16, 2025.
CACI International Inc. director Philip O. Nolan reported the exercise or conversion of 85 restricted stock units on October 11, 2026, corresponding to the acquisition of 85 CACI common shares. He held 2,407 common shares directly afterward, and the reported restricted stock unit balance following the transaction was 0. The units were part of a 338-unit award granted October 16, 2025, with scheduled vesting installments of 84, 84, 85 and 85 units through October 11, 2026.
Susan M. Gordon, a director of CACI International Inc., reported the conversion of 85 restricted stock units into 85 CACI common shares on October 11, 2026. She directly held 2,811 CACI common shares after the transaction, and the reported restricted stock unit balance was zero. The units came from a 338-unit grant made October 16, 2025, scheduled to vest in installments of 84 units on January 15, 2026, 84 on April 15, 2026, 85 on July 15, 2026, and 85 on October 11, 2026.
CACI International Inc. director Stanton D. Sloane converted 85 Restricted Stock Units into 85 shares of CACI common stock on October 11, 2026. His reported direct common-stock holdings after the transaction were 1,197 shares, and his reported Restricted Stock Unit balance was zero.
CACI International Inc. EVP, General Counsel J. William Koegel Jr. reported conversion of 4,371 performance and restricted stock units into 4,371 CACI common shares on October 1, 2026. On that date, he also reported 2,064 common shares delivered or withheld for payment of exercise price or tax liability, at a reported $627.06 per share.
Koegel was also granted 1,197 performance restricted stock units and 1,196 restricted stock units on October 1, 2026.
CACI EVP, Electronic Warfare Tom Kirkland received awards of 798 performance restricted stock units and 797 restricted stock units on October 1, 2026. His reported direct position following the grants was 798 performance restricted stock units and 797 restricted stock units, respectively. The performance units vest on the third anniversary of the grant date based on achievement of a three-year performance measure; the other units vest one-third per year for three years.
James F. Norcross, CACI's EVP, Dig. and Ent. Solutions, reported converting performance and restricted stock units into 1,420 CACI common shares on October 1, 2026. The converted units included 1,036 performance units and restricted-unit amounts of 173, 107 and 104 shares. He was also granted 798 performance restricted stock units, which vest on the third anniversary based on a three-year performance measure, and 797 restricted stock units, which vest one-third per year for three years. 485 shares were delivered or withheld for payment of exercise price or tax liability at $627.06 per share.
CACI International Inc. reported that EVP, Mission and Eng. Support Meisha Lutsey exercised or converted RSUs and PRSUs into 3,497 CACI common shares on October 1, 2026. On the same date, 1,480 shares were delivered or withheld for payment of exercise price or tax liability, at a reported $627.06 per share.
Lutsey also received grants of 638 performance RSUs and 638 RSUs. The performance units vest on the third anniversary based on a three-year performance measure; the RSUs vest one-third per year for three years.
CACI Chief Financial Officer Jeffrey D. Maclauchlan reported converting 8,739 performance and restricted stock units into CACI common shares on October 1, 2026. On that date, 4,288 shares were delivered or withheld for payment of exercise price or tax liability, reported at $627.06 per share.
Maclauchlan also received grants of 2,393 performance restricted stock units and 2,392 restricted stock units. No Rule 10b5-1 plan is reported.
CACI's EVP, Chief Operating Officer David Anthony Young was granted 1,595 performance restricted stock units on October 1, 2026; they vest on the third anniversary based on achievement of a three-year performance measure. He was also granted 1,595 restricted stock units, which vest one-third per year for three years. Both awards were reported as directly held derivative securities.
CACI International Inc. Chief Executive Officer, UK Tracy Weir reported transactions dated October 1, 2026. The report records conversions of 638 performance restricted stock units and 107, 87 and 96 restricted stock units into matching amounts of CACI common stock. It also lists 300, 51, 41 and 46 common shares delivered or withheld for payment of exercise price or tax liability, each at $627.06 per share. Weir received grants of 317 performance restricted stock units and 316 restricted stock units that day.
CACI President & CEO John S. Mengucci reported converting performance and restricted stock units into 47,184 CACI common shares on October 1, 2026. He also had 21,283 shares delivered or withheld for payment of exercise price or tax liability at $627.06 per share.
On the same date, Mengucci was granted 11,961 performance restricted stock units, which vest on the third anniversary based on a three-year performance measure, and 11,961 restricted stock units, which vest 1/3 per year for three years.
CACI International Inc. reports that SVP, Corp. Controller & CAO Eric Blazer converted 66 and 64 restricted stock units into CACI common stock on October 1, 2026. Two separate entries each report 20 shares delivered or withheld for payment of exercise price or tax liability at $627.06 per share. On the same date, Blazer was granted 160 performance restricted stock units and 159 restricted stock units. The performance units vest on the third anniversary based on achievement of a three-year performance measure; the other units vest one-third per year for three years.
DISBROW LISA S reported acquisition or exercise transactions in this Form 4 filing.
CACI International director Lisa S. Disbrow reported an equity grant of 58 shares of CACI common stock on July 30, 2026, received in connection with her annual retainer as Chair of the Board. After this grant, she directly holds 2,510 shares of CACI common stock.
Director Charles L. Szews exercised 85 Restricted Stock Units into 85 shares of CACI common stock on July 13, 2026. These RSUs are part of a 338-unit grant dated October 16, 2025 with scheduled vesting through October 11, 2026. Following the transaction, Szews holds 584 CACI common shares and 85 RSUs directly.
Director Philip O. Nolan acquired 85 shares of CACI common stock through the vesting and conversion of Restricted Stock Units. This compensation-related transaction involved no open-market buying or selling. Following the transaction, he directly holds 2,322 CACI shares and 85 RSUs from a prior grant of 338 RSUs that vest in four installments.
CACI INTERNATIONAL INC /DE/ director Scott C. Morrison reported the vesting and conversion of 85 Restricted Stock Units into 85 shares of CACI Common Stock on July 13, 2026. These RSUs are part of a 338-unit grant awarded on October 16, 2025, with multiple scheduled vesting dates. Following this event, Morrison holds 584 common shares and 85 RSUs directly.
CACI International Inc. director Sloane Stanton reported a derivative exercise/conversion involving 85 Restricted Stock Units and a corresponding 85-share change in CACI common stock on July 13, 2026. Following the transactions, he holds 1,112 shares of CACI common stock directly and 85 Restricted Stock Units. A prior grant of 338 RSUs, awarded on October 16, 2025, vests in four installments: 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026.
CACI International director Lisa S. Disbrow reported the vesting and conversion of 123 Restricted Stock Units into 123 shares of CACI common stock on July 13, 2026. This compensation-related derivative exercise increased her directly held common stock to 2,452 shares.
The RSUs relate to a grant of 492 units made on October 16, 2025, scheduled to vest in four equal installments of 123 shares on January 14, 2026, April 14, 2026, July 13, 2026 and October 11, 2026.
CACI International director Ryan D. McCarthy exercised restricted stock units on July 13, 2026, acquiring 85 shares of CACI common stock through a derivative conversion. After the transaction, he holds 2,322 common shares directly and 85 restricted stock units that are scheduled to vest in a later tranche.
CACI International director Debora A. Plunkett reported the vesting and conversion of 85 Restricted Stock Units into CACI common stock on July 13, 2026. After this derivative exercise, she directly holds 2,597 CACI common shares and retains 85 RSUs from a 338-unit grant awarded on October 16, 2025.
CACI International Inc. director Susan M. Gordon acquired 85 shares of CACI Common Stock on July 13, 2026 through the exercise and conversion of Restricted Stock Units (RSUs), not an open-market purchase. After this vesting event, she directly holds 2,726 common shares and 85 RSUs scheduled to vest on October 11, 2026.
Young David Anthony reported acquisition or exercise transactions in this Form 4 filing.
CACI International executive David Anthony Young, EVP and Chief Operating Officer, received a grant of 4,448 restricted stock units on June 22, 2026. These units represent rights linked to CACI Common Stock and vest in three equal annual installments on June 22, 2027, June 22, 2028 and June 22, 2029.
CACI International director Susan M. Gordon reported an open-market sale of CACI Common Stock. On June 16, she sold 264 shares at a price of $500.38 per share. After this transaction, she directly holds 2,641 shares of CACI Common Stock.
CACI International executive DeEtte Gray, President of US Operations, exercised previously granted equity awards that vested on April 26, 2026. She converted 10,636 restricted stock units into an equal number of CACI common shares and, in a separate step, 4,512 shares were withheld to cover tax obligations at a value of $516.54 per share, rather than sold in the open market. After these transactions, she holds 39,485 CACI common shares directly, reflecting routine compensation-related activity rather than discretionary buying or selling.
DISBROW LISA S reported acquisition or exercise transactions in this Form 4 filing.
CACI International director Lisa S. Disbrow received a grant of 52 shares of CACI common stock on April 16, 2026 as part of her annual retainer for serving as Chair of the Board. This compensation award increased her directly held stake to 2,329 shares.
CACI International director Susan M. Gordon exercised restricted stock units into common shares. On April 14, 2026, she converted 84 Restricted Stock Units into 84 shares of CACI Common Stock, a non-cash derivative exercise.
Following the transaction, she directly held 2,905 shares of CACI Common Stock and 170 Restricted Stock Units. A prior grant on October 17, 2025 awarded 338 RSUs, scheduled to vest in four tranches: 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026.
Director Ryan D. McCarthy of CACI International Inc. exercised 84 Restricted Stock Units on April 14, 2026, converting them into 84 shares of CACI Common Stock at an exercise price of $0.00 per share. After this transaction, he directly owns 2,237 shares of CACI Common Stock and 170 Restricted Stock Units. The exercised RSUs are part of a 338-unit grant awarded on October 17, 2025, scheduled to vest in four installments through October 11, 2026. This filing reflects a routine compensation-related derivative exercise rather than an open-market stock purchase or sale.
CACI International director Scott C. Morrison exercised restricted stock units into common shares as part of a scheduled equity award. On April 14, 2026, 84 RSUs converted into 84 shares of CACI Common Stock at a stated price of $0.00 per share, increasing his direct holdings to 499 shares. A prior grant of 338 RSUs made on October 17, 2025 is scheduled to vest in four tranches: 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026.
CACI International director Philip O. Nolan exercised restricted stock units into common shares as part of his equity compensation. On April 14, 2026, 84 RSUs converted into 84 shares of CACI common stock at a stated price of $0.00 per share, a non-cash equity award.
Following the transaction, Nolan directly held 2,237 CACI common shares and 170 restricted stock units. The footnote explains these RSUs come from a grant of 338 RSUs on October 17, 2025, vesting in four scheduled tranches through October 2026, indicating this is a routine, pre-set vesting event rather than an open-market trade.
CACI International director Lisa S. Disbrow exercised 123 Restricted Stock Units into 123 shares of CACI common stock on April 14, 2026. This transaction increased her direct common share holdings to 2,277 shares and left 246 Restricted Stock Units outstanding from a 492-unit grant awarded on October 16, 2025.
CACI International director Debora A. Plunkett exercised 84 Restricted Stock Units into 84 shares of CACI common stock at a stated price of $0.00 per share. The RSUs are part of a 338-unit grant awarded on October 17, 2025 with scheduled vesting dates through October 11, 2026. Following this transaction, she holds 2,512 shares of CACI common stock directly and 170 RSUs that remain unvested from the same grant.
CACI International director Charles L. Szews reported an exercise of 84 Restricted Stock Units into CACI common stock. The transaction occurred on April 14, 2026 and increased his directly held common shares to 499.
The 84 RSUs exercised are part of a 338-unit grant awarded on October 17, 2025, vesting in four tranches: 84 shares on January 14, 2026, 84 on April 14, 2026, 85 on July 13, 2026, and 85 on October 11, 2026. This filing reflects a routine compensation-related vesting and share delivery, with no open-market buying or selling.
CACI International director Stanton D. Sloane exercised restricted stock units into common shares as part of a vesting schedule. On April 14, 2026, 84 Restricted Stock Units converted into 84 shares of CACI common stock at an exercise price of $0.00 per share, increasing his direct holdings to 1,027 common shares.
These RSUs come from a grant of 338 units awarded on October 17, 2025, which vests in four installments through October 2026. The transaction reflects routine, compensation-related equity vesting rather than an open-market purchase or sale.
Director Debora A. Plunkett reported an open-market sale of 220 shares of CACI Common Stock on March 11, 2026 at an average price of $603.30 per share. After this transaction, she directly holds 2,428 shares of CACI common stock.
CACI International executive J. William Koegel Jr., EVP and General Counsel, reported an insider stock sale. On February 10, 2026, he executed an open-market sale of 2,000 shares of CACI Common Stock at $615.0625 per share. Following this transaction, he directly owned 25,931 shares of CACI Common Stock.